FRMD6-AS2
gene geneOn this page
Summary
FRMD6-AS2 (FRMD6 antisense RNA 2, HGNC:43637) is a long non-coding RNA gene on chromosome 14q22.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43637 |
| Approved symbol | FRMD6-AS2 |
| Name | FRMD6 antisense RNA 2 |
| Location | 14q22.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000258537 |
| Ensembl biotype | lncRNA |
| Entrez | 100874185 |
| RNAcentral | URS000075B3AA — lncRNA, 613 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 lncRNA
ENST00000556617, ENST00000556762, ENST00000557625, ENST00000616999, ENST00000617151, ENST00000697566, ENST00000697567, ENST00000697568, ENST00000697569, ENST00000743446, ENST00000743447, ENST00000743448, ENST00000743449, ENST00000743450, ENST00000743451
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000556617 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002471067 | 51454512 | 51454815 |
| ENSE00002525235 | 51584166 | 51584283 |
| ENSE00003970986 | 51599827 | 51599952 |
Expression profiles
Bgee: expression breadth ubiquitous, 106 present calls, max score 91.19.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2126 / max 101.0119, expressed in 39 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 143199 | 0.0660 | 20 |
| 143194 | 0.0495 | 10 |
| 143200 | 0.0392 | 16 |
| 143197 | 0.0196 | 8 |
| 143196 | 0.0169 | 5 |
| 143198 | 0.0094 | 3 |
| 143195 | 0.0090 | 3 |
| 207215 | 0.0029 | 2 |
Top tissues by expression
106 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.19 | gold quality |
| myometrium | UBERON:0001296 | 90.42 | gold quality |
| body of uterus | UBERON:0009853 | 90.41 | gold quality |
| uterine cervix | UBERON:0000002 | 80.93 | gold quality |
| endocervix | UBERON:0000458 | 79.91 | gold quality |
| left uterine tube | UBERON:0001303 | 79.85 | gold quality |
| ectocervix | UBERON:0012249 | 79.67 | gold quality |
| bone marrow cell | CL:0002092 | 75.78 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 73.98 | gold quality |
| muscle tissue | UBERON:0002385 | 71.93 | gold quality |
| fallopian tube | UBERON:0003889 | 71.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 71.52 | gold quality |
| stromal cell of endometrium | CL:0002255 | 68.80 | gold quality |
| endometrium | UBERON:0001295 | 68.22 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 68.02 | gold quality |
| left ovary | UBERON:0002119 | 67.78 | gold quality |
| ovary | UBERON:0000992 | 67.28 | gold quality |
| urinary bladder | UBERON:0001255 | 66.10 | gold quality |
| right ovary | UBERON:0002118 | 65.59 | gold quality |
| vagina | UBERON:0000996 | 64.91 | gold quality |
| colon | UBERON:0001155 | 62.95 | gold quality |
| intestine | UBERON:0000160 | 61.75 | gold quality |
| fundus of stomach | UBERON:0001160 | 61.60 | gold quality |
| prostate gland | UBERON:0002367 | 61.53 | gold quality |
| lower esophagus | UBERON:0013473 | 60.07 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 60.06 | gold quality |
| tonsil | UBERON:0002372 | 59.88 | gold quality |
| gall bladder | UBERON:0002110 | 59.26 | gold quality |
| transverse colon | UBERON:0001157 | 58.51 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 57.74 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.28 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.